Login / Signup

Heterogeneity in protocols and outcomes to study the effect of renin-angiotensin system blockers in inflammatory bowel disease: A systematic review.

Mariana Ferreira-DuarteFernanda S ToninMargarida Duarte-AraújoFernando Fernandez-LllimosManuela Morato
Published in: Fundamental & clinical pharmacology (2023)
Lack of standardization of protocols and outcomes among studies threatens the evidence on how RAS blockers influence IBD outcomes.
Keyphrases
  • angiotensin converting enzyme
  • single cell
  • type diabetes
  • metabolic syndrome
  • ulcerative colitis